Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (19)

2024

  1. MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  2. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

2022

  1. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

2021

  1. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  2. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. 1H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer

    Journal of Proteome Research, Vol. 19, Núm. 6, pp. 2419-2428

  2. The urinary transcriptome as a source of biomarkers for prostate cancer

    Cancers, Vol. 12, Núm. 2

2018

  1. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer

    Cell Death and Disease, Vol. 9, Núm. 10

  2. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  3. PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth

    Cancer Research, Vol. 78, Núm. 2, pp. 399-409

2017

  1. MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature, Vol. 547, Núm. 7661, pp. 109-113

2016

  1. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

  2. Vesicle-MaNiA: Extracellular vesicles in liquid biopsy and cancer

    Current Opinion in Pharmacology, Vol. 29, pp. 47-53

2015

  1. Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

    Methods, Vol. 77, pp. 25-30

2010

  1. Bladder amyloidosis: A lesion that simulates a tumor

    Actas Urologicas Espanolas

  2. ¿podemos predecir el íleo postoperatorio tras cistectomía radical?

    Actas Urologicas Espanolas, Vol. 34, Núm. 7, pp. 630-633

2009

  1. Editorial: Cual es el "gold standard" en la cirugía de la HBP?

    Archivos Espanoles de Urologia, Vol. 62, Núm. 2, pp. 93-95

  2. ¿implica el T0 en la pieza de cistectomía encontrarse libre de tumor a largo plazo?

    Actas Urologicas Espanolas, Vol. 33, Núm. 8, pp. 865-868